# Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex

> **NCT02634931** · PHASE3 · COMPLETED · sponsor: **Nobelpharma** · enrollment: 94 (actual)

## Conditions studied

- Tuberous Sclerosis
- Angiofibroma
- Hypomelanotic Macule
- Plaque

## Interventions

- **DRUG:** NPC-12G gel

## Key facts

- **NCT ID:** NCT02634931
- **Lead sponsor:** Nobelpharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2019-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02634931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02634931, "Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02634931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*